EXOZYMES INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $-9.2M | $-5.9M | $-2.0M |
| Depreciation & Amortization | — | — | — |
| Depreciation | $288.0K | $267.4K | $196.9K |
| Amortization | — | — | — |
| Stock-Based Compensation | $2.0M | $1.1M | $281.5K |
| Net Cash from Operating Activities | $-6.5M | $-8.5M | $-1.2M |
| Investing Activities | |||
| Capital Expenditures | $169.9K | $396.5K | $288.7K |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | $-150.2K | $-359.2K | $-311.2K |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $-27.7K | $18.5M | $1.0M |
| Net Change in Cash | $-6.7M | $9.7M | $-492.0K |
| Free Cash Flow | $-6.7M | $-8.9M | $-1.5M |